Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries-Reference-Cited by-同舟云学术

Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries

Published:2017-12 Issue:6 Volume:67 Page:1348-1350
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

da Silva Filipe Ana,Sreenu Vattipally,Hughes Joseph,Aranday-Cortes Elihu,Irving William L.,Foster Graham R.,Agarwal Kosh,Rosenberg William,Macdonald Douglas,Richardson Paul,Aldersley Mark A.,Wiselka Martin,Ustianowski Andrew,McLauchlan John,Thomson Emma C.

Publisher

Elsevier BV

Subject

Hepatology

Reference10 articles.

1. NS5A resistance-associated substitutions in patients with genotype 1 hepatitis C virus: Prevalence and effect on treatment outcome;Zeuzem;J Hepatol,2017

2. EASL recommendations on treatment of hepatitis C 2016;J Hepatol,2017

3. Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis;Cheung;J Hepatol,2016

4. Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis;Foster;J Hepatol,2016

5. Post-treatment resistance analysis of hepatitis C virus from phase II and III clinical trials of ledipasvir/sofosbuvir;Wyles;J Hepatol,2017

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients;JHEP Reports;2024-07

2. Identification of 2 Novel Subtypes of Hepatitis C Virus Genotype 8 and a Potential New Genotype Successfully Treated With Direct Acting Antivirals;The Journal of Infectious Diseases;2024-05-08

3. Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure;JHEP Reports;2024-03

4. Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study;eLife;2023-01-09

5. Prevalence of Drug Resistance Associated Substitutions in Hepatitis C-Infected Patients Whose WHO-Recommended Direct Acting Agents for Initial Treatment and Retreatment Fails: A Systematic Review and Meta-Analysis;2023